147 related articles for article (PubMed ID: 9548202)
1. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
2. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
[TBL] [Abstract][Full Text] [Related]
4. Uptake of the 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry.
García-Salinas L; Ferro-Flores G; Arteaga-Murphy C; Pedraza-López M; Hernández-Gutiérrez S; Azorin-Nieto J
Appl Radiat Isot; 2001 Mar; 54(3):413-8. PubMed ID: 11214875
[TBL] [Abstract][Full Text] [Related]
5. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
6. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
7. Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissue.
Seifert S; Syhre R; Spies H; Johannsen B
Nucl Med Commun; 2003 Nov; 24(11):1175-83. PubMed ID: 14569172
[TBL] [Abstract][Full Text] [Related]
8. Preparation of [186Re]Re-DMSA and its bio-distribution studies.
Kothari K; Pillai MR; Unni PR; Shimpi HH; Noronha OP; Samuel AM
Appl Radiat Isot; 1999 Jul; 51(1):43-9. PubMed ID: 10376320
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
10. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
Awh OD; Kim JR; Shim SC
Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
[TBL] [Abstract][Full Text] [Related]
11. Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.
Singh J; Reghebi K; Lazarus CR; Clarke SE; Callahan AP; Knapp FF; Blower PJ
Nucl Med Commun; 1993 Mar; 14(3):197-203. PubMed ID: 8384352
[TBL] [Abstract][Full Text] [Related]
12. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ
Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
[TBL] [Abstract][Full Text] [Related]
13. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake.
de Lange MJ; Piers DA; Kosterink JG; van Luijk WH; Meijer S; de Zeeuw D; van der Hem GK
J Nucl Med; 1989 Jul; 30(7):1219-23. PubMed ID: 2544699
[TBL] [Abstract][Full Text] [Related]
14. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J
Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362
[TBL] [Abstract][Full Text] [Related]
15. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
16. DA-7911, 188Rhenium-tin colloid, as a new therapeutic agent of rheumatoid arthritis.
Shin CY; Son M; Ko JI; Jung MY; Lee IK; Kim SH; Kim WB; Jeong JM; Song YW
Arch Pharm Res; 2003 Feb; 26(2):168-72. PubMed ID: 12643596
[TBL] [Abstract][Full Text] [Related]
17. Relative and absolute 99Tcm-DMSA uptake measurements in normal and obstructed kidneys.
Zananiri MC; Jarritt PH; Sarfarazi M; Ell PJ
Nucl Med Commun; 1987 Nov; 8(11):869-80. PubMed ID: 2831486
[TBL] [Abstract][Full Text] [Related]
18. Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations.
Gomes ML; de Mattos DM; de Souza Freitas R; Bezerra RJ; Bernardo-Filho M
Hum Exp Toxicol; 2001 Apr; 20(4):193-7. PubMed ID: 11393272
[TBL] [Abstract][Full Text] [Related]
19. The determination of relative kidney function in obstructive uropathy with 99Tcm-DMSA.
Pauwels EK; Lycklama à Nijeholt AA; Arndt JW; Jonas U
Nucl Med Commun; 1987 Nov; 8(11):865-7. PubMed ID: 2831485
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of (99m)Tc-DMSA lyophilized kit for renal imaging.
Jan SU; Abbass HG
Pak J Pharm Sci; 2013 May; 26(3):547-51. PubMed ID: 23625428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
